PMID: 380461Mar 1, 1979Paper

Synergistic effects of ampicillin-aminoglycoside combinations on group B streptococci

Antimicrobial Agents and Chemotherapy
M D CooperE L Cheatle

Abstract

The in vitro activity of gentamicin, tobramycin, kanamycin, and amikacin in combination with ampicillin was determined against aminoglycoside-resistant group B streptococci. Synergy in each combination was determined by quantitative kill curves and demonstrated in all the combinations tested.

References

Aug 1, 1976·The Journal of Pediatrics·D D BroughtonM S Cohen
Aug 1, 1976·The Journal of Pediatrics·V SchaufA Serota
Sep 1, 1974·American Journal of Diseases of Children·G H McCracken
Dec 1, 1974·American Journal of Diseases of Children·J B Howard, G H McCracken

Citations

Aug 14, 2010·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M GranlundSwedish Working Group for the Prevention of Perinatal Group B Streptococcal Infections
May 5, 1979·Canadian Medical Association Journal·D Schiff
Feb 8, 2003·Diagnostic Microbiology and Infectious Disease·Katherine K HsuDaniel S Shapiro
Sep 2, 1999·Infectious Disease Clinics of North America·A Pong, J S Bradley
Dec 1, 1991·Zentralblatt für Veterinärmedizin. Reihe B. Journal of veterinary medicine. Series B·I W WibawanC Lämmler
May 1, 1981·Antimicrobial Agents and Chemotherapy·C N BakerR R Facklam
Sep 1, 1981·Antimicrobial Agents and Chemotherapy·J L WeeksC J Baker
Jun 1, 1990·Antimicrobial Agents and Chemotherapy·A Buu-HoïT Horaud
Mar 28, 2017·Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy·Yoshifumi EbaraSatoshi Iwata
Jan 27, 2019·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Parham Sendi

Related Concepts

Aminoglycosides
Ukapen
Antibiotics
Drug Augmentation
Streptococcus agalactiae

Related Feeds

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.